Literature DB >> 2578285

The prognostic value of the monoclonal antibodies HMFG1 and HMFG2 in breast cancer.

N Berry, D B Jones, J Smallwood, I Taylor, N Kirkham, J Taylor-Papadimitriou.   

Abstract

The monoclonal antibodies HMFG1 and HMFG2 identify antigens of the milk fat globule membrane which are also found on breast epithelial cells. Immunohistochemical staining was performed using both antibodies on formalin fixed, paraffin embedded sections of 93 breast carcinoma, 36 histologically benign lesions and 29 histologically normal breast tissue blocks. In both normal and benign breast disease the staining was largely extracellular whilst in malignant tissue the staining was variable and often intracellular. Nine carcinomas did not stain with either antibody. The staining patterns of malignant tissues were graded and no correlation was found between the grades and survival or indices of prognosis, (the oestrogen receptor status, Bloom's grade and the presence or absence of metastases to the axillary nodes.) This study indicates that with the present methods available for grading staining patterns, although of diagnostic value, these monoclonal antibodies are unlikely to assist in determining either the degree of tumour differentiation or prognosis in breast carcinoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2578285      PMCID: PMC1977039          DOI: 10.1038/bjc.1985.27

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  18 in total

1.  Intracytoplasmic lumina in breast carcinoma: a helpful histopathologic feature.

Authors:  H Battifora
Journal:  Arch Pathol       Date:  1975-11

2.  A new antigen on the epithelial membrane: its immunoperoxidase localisation in normal and neoplastic tissue.

Authors:  E Heyderman; K Steele; M G Ormerod
Journal:  J Clin Pathol       Date:  1979-01       Impact factor: 3.411

3.  The use of proteolytic enzymes to improve immunoglobulin staining by the PAP technique.

Authors:  B L Mepham; W Frater; B S Mitchell
Journal:  Histochem J       Date:  1979-05

4.  Surface differentiation antigens of human mammary epithelial cells carried on the human milk fat globule.

Authors:  R L Ceriani; K Thompson; J A Peterson; S Abraham
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

5.  A computer program for comparing K samples with right-censored data.

Authors:  E T Lee; M M Desu
Journal:  Comput Programs Biomed       Date:  1972-11

6.  Monoclonal antibodies to epithelium-specific components of the human milk fat globule membrane: production and reaction with cells in culture.

Authors:  J Taylor-Papadimitriou; J A Peterson; J Arklie; J Burchell; R L Ceriani; W F Bodmer
Journal:  Int J Cancer       Date:  1981-07-15       Impact factor: 7.396

7.  Distribution of epithelial membrane antigen in normal and neoplastic tissues and it value in diagnostic tumor pathology.

Authors:  J P Sloane; M G Ormerod
Journal:  Cancer       Date:  1981-04-01       Impact factor: 6.860

8.  Oestrogen receptors and prognosis in early breast cancer.

Authors:  T Cooke; D George; R Shields; P Maynard; K Griffiths
Journal:  Lancet       Date:  1979-05-12       Impact factor: 79.321

9.  The use of antisera to epithelial membrane antigen in detecting micrometastases in histological sections.

Authors:  J P Sloane; M G Ormerod; S F Imrie; R C Coombes
Journal:  Br J Cancer       Date:  1980-09       Impact factor: 7.640

10.  Patterns of relapse and survival in operable breast carcinoma with positive and negative axillary nodes.

Authors:  P Valagussa; G Bonadonna; U Veronesi
Journal:  Tumori       Date:  1978-06-30
View more
  16 in total

1.  Tenascin is a stromal marker for epithelial malignancy in the mammary gland.

Authors:  E J Mackie; R Chiquet-Ehrismann; C A Pearson; Y Inaguma; K Taya; Y Kawarada; T Sakakura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Critical evaluation of monoclonal antibody staining in breast carcinoma.

Authors:  D M Parham; G Coghill; A J Robertson
Journal:  J Clin Pathol       Date:  1989-08       Impact factor: 3.411

Review 3.  CAR T cells redirected against tumor-specific antigen glycoforms: can low-sugar antigens guarantee a sweet success?

Authors:  Pooria Safarzadeh Kozani; Pouya Safarzadeh Kozani; Fatemeh Rahbarizadeh
Journal:  Front Med       Date:  2022-06-10       Impact factor: 9.927

4.  Expression of MUC2 epithelial mucin in breast carcinoma.

Authors:  M D Walsh; M A McGuckin; P L Devine; B G Hohn; R G Wright
Journal:  J Clin Pathol       Date:  1993-10       Impact factor: 3.411

5.  Quantitation of human milk fat globule (HMFG1) expression in breast carcinoma and its association with survival.

Authors:  D M Parham; W Slidders; A J Robertson
Journal:  J Clin Pathol       Date:  1988-08       Impact factor: 3.411

6.  Prognostic significance of the immunohistochemical reaction to human milk fat globule antibodies in node-negative and node-positive breast cancer.

Authors:  E E Sterns; W A Fletcher; B Zee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

7.  Monoclonal antibody BrE-3 participation in a multivariate prognostic model for infiltrating ductal carcinoma of the breast.

Authors:  C M Chan; F S Baratta; L Ozzello; R L Ceriani
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

8.  Comparison of monoclonal antibodies for the detection of occult breast carcinoma metastases in bone marrow.

Authors:  A Thor; M J Viglione; N Ohuchi; J Simpson; R Steis; J Cousar; M Lippman; D W Kufe; J Schlom
Journal:  Breast Cancer Res Treat       Date:  1988-05       Impact factor: 4.872

9.  Immunohistochemical reaction to human milk fat globule antibodies and breast cancer differentiation.

Authors:  E E Sterns; W A Fletcher; B Zee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

10.  Assessment of milk fat globule membrane antibodies and lectins as markers of short-term prognosis in breast cancer.

Authors:  R A Walker
Journal:  Br J Cancer       Date:  1990-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.